维普期刊资源整合服务平台（V6.5）

127篇 您的检索式：作者名="LAMPERTICO P"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine显示文摘	DiMarco V Marzano A Lampertico P	2004	Hepatology2004，40，5：	1
2	Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics 显示文摘	Lampertico P Maher J S Gerber M A	1991	Hepatology1991，13，3：	1
3	Long -term outcome of hepatitis B in lamivudine-resistant cirrhotic patients显示文摘	Lampertico P Vigano M Romeo R	2002	J Hepatol2002，，：	1
4	Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics显示文摘	Lampertico P Malter JS Gerber MA	1991	Hepatology1991，13，3：	1
5	Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistance hepatitis B patients显示文摘	Lampertico P Vigano M Manenti E	2007	Gastroenterology2007，133，5：	1
6	A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum显示文摘	Lampertico P Del Ninno E manzin A	1997	Hepatology1997，26，：	1
7	Restoredfunction of HBV - specific T cells after long - term effectivetherapy with nucleos(t) ide analogues显示文摘	BONI C LACCABUE D LAMPERTICO P	2012	Gastroenterolo-gy2012，143，4：	1
8	Long-term outcome of hepatitis B in lamivudine-resistant cirrhotic patients显示文摘	LAMPERTICO P VIGANO M ROMEO R	2002	J Hepatol2002，36，1：	1
9	Low resistance to adefovir combined with lamivudine 3-year study of 145 lamivudine-resistant hepatitis B patients显示文摘	Lampertico P Vigano M Manenti E et a!	2007	Gastroenterology2007，133，：	1
10	Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine显示文摘	Lampertico P Vigano M Manenti E	2005	Hepatology2005，42，：	1
11	Development and application of anin vitro model for screening anti-hepatitis B virus therapeutics显示文摘	Lampertico P Malter JS Gerber MA	1991	Hepatology1991，13，3：	1
12	A radomised, controlled trial of a 24 month course of interferon alfa2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum 显示文摘	Lampertico P Del Ninno E Maszin A	1997	Hepatology1997，26，6：	1
13	Response-guided peginterferon alfa-2a therapy based on HBsAg levels at week 12 and week 24 or 48 improves respose rates in HBeAg negative genotype D patients显示文摘	Lampertico P Vigano M Di Costanzo GC		0，，2：	1
14	Hepatotropic viruses : new insights in pathogenesis and treatment 显示文摘	Gatta A Giannini C Lampertico P	2008	Clin Exp Rheumatol2008，26，148：	1
15	Low Resistance to Adefovir Combined with Lamivudine: a 3-year Study of 145 Lamivudine-resistant Hepatitis B Patients显示文摘	Lampertico P Vigano M Manenti E	2007	Gastroenterology2007，133，：	1
16	Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B By 24-month interferon therapy显示文摘	Lampertico P Del Ninno E Viganò M		Hepatology0，，：	1
17	Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine显示文摘	Di Marco V Marzano A Lampertico P	2004	Hepatology2004，40，：	1
18	IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroelearance in genotype D hepatitis B e mltigen- negative patients with chronic hepatitis B 显示文摘	Lampertico P Viganb M Cheroni C	2013	Hepatol2013，57，3：	1
19	Clinical evaluation and applications of the Amplicor HBV Monitor test,a quantitative HBV DNA PCR assay显示文摘	Gerken G Gomes J Lampertico P	1998	J Virol Methods1998，74，2：	1
20	Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nu- cleos(t)ide therapy: a systematic review显示文摘	Papatheodoridis GV Lampertico P Manolakopoulos S	2010	J Hepatol2010，53，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示